携带mcr-9基因的肠杆菌对黏菌素敏感性的改良药敏试验与筛查培养基
研究探讨携带mcr-9基因的阴沟肠杆菌复合群在标准肉汤微量稀释法(BMD)中使用不同培养基时对黏菌素的敏感性差异。在CA-MHB中MIC为0.125-0.5 μg/mL(敏感),而在BHI等培养基中MIC显著升高(4-128 μg/mL)。黏菌素可剂量依赖性诱导mcr-9表达,并增加对LL-37的存活率。在93株临床分离株中,仅mcr-9阳性株在BHI中MIC比CA-MHB高至少32倍,且可在含3 μg/mL黏菌素的改良BHI琼脂(MCR9-JU)上生长。提示BHI-BMD与CA-MHB-BMD联用有助于检测mcr-9阳性株,MCR9-JU琼脂可用于筛查。
要点
- mcr-9阳性肠杆菌在CA-MHB中黏菌素MIC为0.125-0.5 μg/mL(敏感),但BHI中MIC升高至4-128 μg/mL。
- 黏菌素可剂量依赖性诱导mcr-9表达,并增强菌株对LL-37的存活率。
- MCR9-JU琼脂(含3 μg/mL黏菌素)可筛查mcr-9阳性及其他黏菌素耐药肠杆菌。
核心结论
- BHI-BMD与CA-MHB-BMD联用可检测mcr-9阳性肠杆菌,MCR9-JU琼脂可用于筛查mcr-9阳性及其他黏菌素耐药株。
研究设计与样本
- 研究采用3株携带mcr-9的阴沟肠杆菌复合群临床分离株和93株肠杆菌科临床分离株,进行BMD试验(CA-MHB、BHI、LB、TSB及补充酪蛋白、胰蛋白胨或蛋白胨的CA-MHB)和MCR9-JU琼脂生长试验。
主要发现
- mcr-9阳性株在CA-MHB中黏菌素MIC为0.125-0.5 μg/mL,在BHI中MIC为4-128 μg/mL。
- 黏菌素剂量依赖性诱导mcr-9表达,并显著增加mcr-9阳性株和携带mcr-9的E. coli DH5α对LL-37的存活率。
- ESI-TOF MS显示携带mcr-9的E. coli DH5α经黏菌素处理后脂质A部分被磷酸乙醇胺修饰。
- 93株临床分离株中仅mcr-9阳性株在BHI中MIC比CA-MHB高至少32倍,并可在MCR9-JU琼脂上生长。
关键数值与推荐
- mcr-9阳性株在CA-MHB中黏菌素MIC为0.125-0.5 μg/mL(按EUCAST指南判为敏感)。
- mcr-9阳性株在BHI中黏菌素MIC为4-128 μg/mL。
- MCR9-JU琼脂含3 μg/mL黏菌素,mcr-9阳性株可生长。
临床怎么用
- 对mcr-9阳性或疑似携带mcr-9的肠杆菌,除CA-MHB-BMD外,可加做BHI-BMD以揭示黏菌素耐药表型。
- MCR9-JU琼脂可用于筛查mcr-9阳性及其他黏菌素耐药肠杆菌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Three isolates of the Enterobacter cloacae complex harboring mcr-9, a member of the colistin resistance mcr gene family encoded on plasmids, were susceptible to colistin, with MICs of 0.125 to 0.5 μg/mL in standard broth microdilution (BMD) tests using cation-adjusted Mueller-Hinton broth (CA-MHB) in accordance with European Committee on Antimicrobial Susceptibility Testing guidelines. In contrast, their MICs for colistin were significantly higher (4 to 128 μg/mL) when BMD tests were performed using brain-heart infusion (BHI) medium, Luria-Bertani (LB) broth, tryptic soy broth (TSB), or CA-MHB supplemented with casein, tryptonen or peptone. Colistin significantly induced mcr-9 expression in a dose-dependent manner when these mcr-9-positive isolates were cultured in BHI or CA-MHB supplemented with peptone/casein. Pretreatment of mcr-9-positive isolates and Escherichia coli DH5α harboring mcr-9 with colistin significantly increased their survival rates against LL-37, a human antimicrobial peptide. Electrospray ionization time-of-flight mass spectrometry analysis showed that a lipid A moiety of lipopolysaccharide was partially modified by phosphoethanolamine in E. coli DH5α harboring mcr-9 when treated with colistin. Of 93 clinical isolates of Enterobacteriaceae, only the mcr-9-positive isolates showed MICs to colistin that were at least 32 times higher in BHI than in CA-MHB. These mcr-9-positive isolates grew on a modified BHI agar, MCR9-JU, containing 3 μg/mL colistin. These results suggest that the BMD method using BHI is useful when performed together with the BMD method using CA-MHB to detect mcr-9-positive isolates and that MCR9-JU agar is useful in screening for Enterobacteriaceae isolates harboring mcr-9 and other colistin-resistant isolates.
引用
- Kananizadeh P, Tada T, Oshiro S, et al. Modified Drug-Susceptibility Testing and Screening Culture Agar for Colistin-Susceptible Enterobacteriaceae Isolates Harboring a Mobilized Colistin Resistance Gene mcr-9. J Clin Microbiol. 2022. PMID: 36445156. doi:10.1128/jcm.01399-22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。